Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
Archives of Environmental Contamination and Toxicology
|
February 15, 2015
Metal release from contaminated estuarine sediment under pH changes in the marine environment
M Camino Martín-Torre, M Cruz Payán, Bram Verbinnen, et al.
Cancers
|
August 26, 2023
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of <i>Ppp2r5d</i>
Judit Domènech Omella, Emanuela E Cortesi, Iris Verbinnen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 10, 2007
Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors
Pierre Raboisson, Oliver Lenz, Tse-I Lin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 18, 2020
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro
Thierry Verbinnen, Ying Tan, Gengyan Wang, et al.
Journal of Viral Hepatitis
|
June 25, 2020
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy
Thierry Verbinnen, Moana Hodari, Willem Talloen, et al.
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase II clinical trials
Thierry Verbinnen, Erkki Lathouwers, John Jezorwski, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme
Abigail Mayer, Rita Derua, Elijah Spahn, et al.
Journal of Virology
|
August 27, 2010
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing
Thierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2012
Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model
Sofie Vets, Janine Kimpel, Andreas Volk, et al.
Antiviral Research
|
June 29, 2023
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study
Thierry Verbinnen, Willem Talloen, Harry L A Janssen, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
Archives of Environmental Contamination and Toxicology
|
February 15, 2015
Metal release from contaminated estuarine sediment under pH changes in the marine environment
M Camino Martín-Torre, M Cruz Payán, Bram Verbinnen, et al.
Cancers
|
August 26, 2023
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of <i>Ppp2r5d</i>
Judit Domènech Omella, Emanuela E Cortesi, Iris Verbinnen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 10, 2007
Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors
Pierre Raboisson, Oliver Lenz, Tse-I Lin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 18, 2020
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro
Thierry Verbinnen, Ying Tan, Gengyan Wang, et al.
Journal of Viral Hepatitis
|
June 25, 2020
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy
Thierry Verbinnen, Moana Hodari, Willem Talloen, et al.
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase II clinical trials
Thierry Verbinnen, Erkki Lathouwers, John Jezorwski, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme
Abigail Mayer, Rita Derua, Elijah Spahn, et al.
Journal of Virology
|
August 27, 2010
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing
Thierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2012
Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model
Sofie Vets, Janine Kimpel, Andreas Volk, et al.
Antiviral Research
|
June 29, 2023
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study
Thierry Verbinnen, Willem Talloen, Harry L A Janssen, et al.
Page
of 10